Rozact-A20 Capsule IR is a combination of blood-thinning agent and cholesterol-lowering agent, primarily used to prevent myocardial infarction (heart attack), stroke or peripheral vascular disease. It is also used to lower abnormally elevated cholesterol or fat levels (hyperlipidaemia or dyslipidaemia) in the body. A heart attack occurs when a blood clot blocks the blood flow to the heart. This blockage of arteries is often an accumulation of fat, cholesterol and other substances, which form a plaque in the arteries that feed the heart (coronary arteries). 

Rozact-A20 Capsule IR is composed of two medicines, namely: Rosuvastatin and Aspirin. Rosuvastatin belongs to the class of antilipemic (cholesterol-lowering) agents. It works by blocking liver enzymes, causing the liver to make less cholesterol. Rosuvastatin lowers the bad cholesterol (low-density lipoprotein or LDL) levels and increases good cholesterol levels (high-density lipoprotein or HDL) in the blood. Aspirin is a non-steroidal anti-inflammatory drug (NSAID) with anti-platelet action. It decreases the formation of blood clots by preventing the platelets from clubbing together. Aspirin acts as a blood-thinning or anti-platelet agent in a low dose (about 75 mg) to prevent heart attack and stroke. Rozact-A20 Capsule IR helps in the free flow of blood, thereby preventing a heart attack, stroke and other peripheral vascular diseases. 

Your doctor will advise you how often you take your tablets based on your medical condition. The common side effects of Rozact-A20 Capsule IR include increased bleeding tendency, nausea, abdominal pain, headache, constipation, muscle pain, weakness, dizziness and indigestion. These side effects do not occur in everyone using Rozact-A20 Capsule IR and may vary individually. If these side effects occur, they resolve gradually over time and do not usually require medical attention. However, if you notice any side effects that are not manageable, it is advised to consult your doctor.

Try not to stop taking this medicine of your own. Stopping Rozact-A20 Capsule IR may worsen your condition and increase the risk of a future heart attack. Let your doctor know if you are sensitive to rosuvastatin or aspirin and have any kidney/liver diseases, asthma, active bleeding issues (like peptic ulcer, brain haemorrhage), gastrointestinal disorders, diabetes, mental illnesses (memory loss, forgetfulness, amnesia, memory impairment, confusion), and musculoskeletal disorders before starting Rozact-A20 Capsule IR. If you are pregnant, planning to conceive or breastfeeding, it is essential to seek medical advice before starting Rozact-A20 Capsule IR. The patient should inform the doctor if he/she is taking Rozact-A20 Capsule IR before any surgery is scheduled or any new medicine is taken.

Rozact-A20 Capsule IR is composed of Rosuvastatin and Aspirin. Rosuvastatin is an antilipemic agent (cholesterol-lowering) or HMG-CoA reductase inhibitor. It works by blocking liver enzymes, causing the liver to make less cholesterol. It also lowers the bad cholesterol (low-density lipoprotein or LDL) levels and increases good cholesterol levels (high-density lipoprotein or HDL) in the blood. Rosuvastatin reduces the risk of coronary events, such as heart attack, stroke and angina (chest pain). Aspirin is a non-steroidal anti-inflammatory (NSAID) and anti-platelet drug that decreases blood clot's formation by preventing the platelets from clubbing together. It is also used in heart-related revascularization procedures (provision of new blood supply to a body part), such as coronary artery bypass graft to improve the blood flow through the revascularized area. Rozact-A20 Capsule IR helps in the free flow of blood, thereby preventing a heart attack, stroke and other peripheral vascular diseases.

Before taking Rozact-A20 Capsule IR, let your doctor know if you have a history of liver and kidney diseases or allergic reactions to aspirin and rosuvastatin. If you are at risk of internal bleeding (bleeding inside any tissues, organs or joints of your body), a recent injury/surgery or a planned surgery (including dental) in the next few days, coagulation disorders, such as haemophilia and thrombocytopenia and active bleeding issues (peptic ulcer, brain haemorrhage), please inform your doctor before starting the medicine. If you are pregnant, planning to conceive or breastfeeding, it is essential to seek medical advice before starting Rozact-A20 Capsule IR. Do not drive or operate machinery if you experience dizziness or drowsiness while using Rozact-A20 Capsule IR. Please do not consume alcohol since it may worsen the side effects like dizziness and increased blood pressure. Rozact-A20 Capsule IR is not recommended for children below the age of 16 years.